BridgeBio Pharma Inc. (BBIO) Said To Attract Interest From Pharma Companies - Bloomberg

March 24, 2023 3:55 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - March 24, 2023 3:58 PM EDT)

BridgeBio Pharma Inc. (NASDAQ: BBIO) is attracting takeover interest from bigger drug companies, according to a report from Bloomberg, citing people familiar with the matter.

Some large pharma companies are studying a potential acquisition of the firm.

Deliberations are ongoing.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Hot Corp. News, Hot M&A, Mergers and Acquisitions

Related Entities

Definitive Agreement